Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
about
Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisA meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weightDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksHow population-level data linkage might impact on dental research.Are women with major depression in pregnancy identifiable in population health data?Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013).Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Pregnant women with posttraumatic stress disorder and risk of preterm birthAntidepressant use in pregnant and postpartum womenExposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort StudiesDepression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Neurotransmitter signaling pathways required for normal development in Xenopus laevis embryos: a pharmacological survey screenAntidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.Association of citalopram with congenital anomalies: A meta-analysisPatterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort.The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births.Antidepressant use during early pregnancy and the risk of congenital anomalies.Use of antidepressants and association with elective termination of pregnancy: population based case-control study.Peripartum antidepressant use is associated with an increased risk of postpartum haemorrhage.Response to: Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics.
P2860
Q21198704-0DE34540-B2B1-4E7D-879F-F9034B73F21CQ24623163-3F3D9206-9BFE-48E2-B132-47C8E56617D3Q26991704-C24B2F59-27E3-4927-8CE3-ADC143C400E9Q30569796-515EB167-2E62-4169-84E4-9A8B9C3D626BQ30599552-CC96CCCA-CB2D-4C3F-A173-8E11ED47BD1CQ30840124-3FD91D41-4CCD-4FED-9492-9003D10580C8Q30921563-B7216FF8-395D-4CE4-9CE5-6F947EE27920Q33816388-410944F4-41E1-4DFD-98FB-92ECCD90DDC1Q34047430-ADFFF55D-462F-48D4-827F-8323C0D71C62Q34053512-12221C0B-9D27-457A-B8D4-8BC4EB8CF17FQ34068023-C2DB4A4F-C533-40F2-A0B9-D8E7633F3528Q34073546-A3812563-3771-4E27-88DF-D753B08D39DCQ34270366-01736E7A-E941-43CA-8AAD-8CE0B4FFF31EQ34516341-E0036441-30D1-4911-B911-CF6303AA0519Q35132422-346D2E9A-91DE-45E5-A256-0E14F2DEA752Q36141324-65F92708-7C74-48E3-97CB-506228FA465BQ36152982-75E5780E-A31E-4912-B992-371BA33155A5Q36209588-571784B3-B0D2-4D8A-8B60-6389714AD3DCQ36648778-F0D3F98C-9B9B-4C61-9418-C834191B4EC0Q36706789-43C2948C-5B59-4982-8562-85E15EA29F04Q37235692-6B4B8D26-F86B-4F36-8B3B-9F8785F3E007Q37612128-B347AED5-6CCA-4354-9C52-28DE42A266B1Q37654878-ABD82ADF-F3FF-4239-9F74-EC89B51705E5Q37718886-B1ED40FB-D0E4-45CD-857F-AB2635C1C4E9Q38174445-4B4F839B-6E85-4F09-BA8E-C1D1757492FFQ38672603-C2148740-1005-41F5-914F-2AB0E8FC197AQ38736763-3C9A15E2-8448-4028-84EB-3CACAACAE99AQ38781285-8FBF56D3-DC02-43D2-AE81-C1969B42AE70Q38811512-684A4E24-5CBC-4BA2-85E1-883AB33A276BQ38823790-884DD8DF-0A9A-42AC-9E1E-152323F07478Q38988107-EA333870-A8FE-4681-8551-9E4AC8EFA4B7Q39886560-66208F8D-D9F7-4B3A-86D5-1960C0D5D820Q40764468-91B7F8F5-D983-4305-BDC0-63A430CC6DDFQ41708862-E6756EC6-12A4-4CE8-9E67-C64B4522EA64Q44215306-51BF60CE-A3F9-4503-B8B7-35A040A34F92Q44432389-D1AEFAC5-0520-404C-9F5F-BE0DD1685FBDQ45399244-ED78EF18-0566-4223-A8B8-D0CB1F5D8DBBQ46315307-82C6F9E7-C3F4-4150-9A96-290ABD6DA288Q46625070-02C6B296-335A-4064-B3BE-6C49CCA612ABQ47940100-6A1DE27B-ED76-49E4-804F-EE1A8A0BA4D1
P2860
Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@en
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@nl
type
label
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@en
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@nl
prefLabel
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@en
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@nl
P2093
P2860
P356
P1476
Dispensing patterns and pregna ...... ptake inhibitors in pregnancy.
@en
P2093
Carol Bower
Fiona J Stanley
Lyn Colvin
P2860
P304
P356
10.1002/BDRA.20773
P577
2011-03-04T00:00:00Z